Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

NCT06700096 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT06700096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06700096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B
Lead sponsor
Biocad
Phase
Phase 3
Overall status
Recruiting
Start date
November 7, 2024
Completion date
March 31, 2032
Enrollment
24 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia b